跳至主要内容
临床试验/NCT01382992
NCT01382992Unknown不适用

A Retrospective EGFR Mutation Status Study in Chinese NSCLC Patients Using Paired Plasma and Tissue Samples

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2010年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
150
试验地点
1
主要终点
To determine the consistence of EGFR mutation status in paired tissue and plasma samples

研究概览

简要总结

EGFR mutations plays an essential role in EGFR-TKIs treatment. However, for some patients, tissue samples are not available. The purpose of this study is to determine whether blood sample is feasible for EGFR mutation detection.For late stage NSCLC, we hypothesis plasma sample is an alternative for detecting EGFR mutations.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Non-small cell lung cancer
  • Available plasma and pathologically confirmed tissue slices(pre-chemo and pre-radio therapy)
  • Informed Consent

排除标准

  • 未提供

结局指标

主要结局

To determine the consistence of EGFR mutation status in paired tissue and plasma samples

时间窗: 3 months

次要结局

  • To determine the EGFR mutation status in Chinese NSCLC(3month)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验